You are here

  • Home
  • Archive
  • Volume 10, Issue 8
  • Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

Article metrics

Article menu
Immunotherapy biomarkers
Original research
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

 

Online download statistics by month:

Online download statistics by month: August 2022 to August 2024

AbstractFullPdf
Aug 2022671699224
Sep 2022817842314
Oct 2022534547155
Nov 2022260264160
Dec 202220020055
Jan 202316116139
Feb 202316216469
Mar 202317918275
Apr 202317718247
May 202314614728
Jun 202313213220
Jul 202315415440
Aug 202316016037
Sep 202316216264
Oct 202325525664
Nov 202312412854
Dec 202315115685
Jan 202414414591
Feb 202412712869
Mar 2024179182147
Apr 202413113191
May 2024149150103
Jun 202412513368
Jul 202413013166
Aug 202412312452
Total555356602217